Orasis Pharmaceuticals Company
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
Technology:
Small Molecules
Industry:
Geroscience
Headquarters:
Herzliya, Tel Aviv, Israel
Founded Date:
2015-01-01
Employees Number:
1-10
Investors Number:
7
Total Funding:
43000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-09-10
Last Funding Type:
Series C
Register and Claim Ownership